Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
05 Jun 2013 Bevacizumab: The First Agent to Remarkably Improve Survival in Recurrent Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
04 Jun 2013 European Medicines Agency recommends approval of pomalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jun 2013 FDA Approves Trametinib and Dabrafenib for Unresectable or Metastatic BRAF-Mutated Melanoma Melanoma - Anticancer agents & Biologic therapy
14 May 2013 EU funded CAMINEMS project combines three emerging technologies – nanotechnology, optical technologies, and microfluidics Translational research
11 May 2013 EMCTO 2013 News: Initial results from the largest prospective study of pulmonary metastasectomy in patients with colorectal cancer Lung and other thoracic tumours
11 May 2013 EMCTO 2013 News: Stereotactic ablative radiotherapy is an effective alternative in patients with multiple primary lung cancers Lung and other thoracic tumours
10 May 2013 EMCTO News: Evaluation of performance of lung cancer screening strategy in the first three rounds of the NELSON trial Cancer prevention - Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: Different survival outcome following diagnosis of metastatic bone disease shown for EGFR mutated NSCLC patients in small retrospective study Translational research - Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: A study of simultaneous occurrence of EGFR mutations and HER2 gene amplifications in large series of NSCLC Translational research - Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: Meta-analysis slightly favours platinum-based first-line treatment in patients with advanced/metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 May 2013 EMCTO 2013 News: First-line gefitinib effective and well tolerated in Caucasian patients with EGFR mutation-positive NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 May 2013 EMCTO 2013 News: Findings support the value of tumour rebiopsy in NSCLC patients Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: Enobosarm improves muscle wasting experienced by patients with NSCLC Palliative and supportive care - Lung and other thoracic tumours
30 Apr 2013 European Medicines Agency recommends granting a conditional marketing authorisation for vismodegib Melanoma - Anticancer agents & Biologic therapy
29 Apr 2013 Adequate supply level has been restored in all EU Member States and pegylated doxorubicin hydrochloride can now be used again without restrictions Breast cancer - Gynaecologic malignancies - Anticancer agents & Biologic therapy